News Focus
News Focus
icon url

BigBadWolf

04/22/26 9:14 AM

#52938 RE: resx18 #52937

We’ll break down todays PR both from an accounting & business perspective in a bit.
icon url

tdbowieknife

04/22/26 9:15 AM

#52939 RE: resx18 #52937

AMFN cannot realistically achieve a Frankfurt dual listing in its current state. Every Frankfurt segment (even the lowest-tier “Scale” inclusion) requires conditions AMFN does not meet, including active trading, disclosures, and a sponsoring Market Maker... And the patents in this situation are worth almost nothing in terms of economic value, valuation support, or credibility. Patent applications are not assets — they are expenses. Even granted patents in fusion are worth very little without a working reactor.

https://resourcehub.bakermckenzie.com/en/resources/cross-border-listings-guide/europe-middle-east--africa/frankfurt-stock-exchange/topics/listing-documentation-and-process

Warning! This security is eligible for Unsolicited Quotes Only

This stock is not eligible for proprietary broker-dealer quotations. All quotes in this stock reflect unsolicited customer orders. Unsolicited-Only stocks have a higher risk of wider spreads, increased volatility, and price dislocations. Investors may have difficulty selling this stock. An initial review by a broker-dealer under SEC Rule15c2-11 is required for brokers to publish competing quotes and provide continuous market making.

https://www.otcmarkets.com/stock/AMFN/overview


.


.

Watch your wallet


Buyer Beware
Social Media Promoted Frontload Pump and Dump Share Selling Scam



..


.
icon url

resx18

04/22/26 9:17 AM

#52940 RE: resx18 #52937

American Fusion is preparing to expand its intellectual property portfolio through a targeted pipeline of additional patent applications, with a development objective of approximately 300 additional filings. These forthcoming applications build upon the Company’s existing portfolio and reflect continued innovation in its Texatron™ fusion platform, with core system design and development led by Chief Technology Officer, Dr. John Brandenburg, including advancements in reactor architecture, plasma behavior, energy conversion, and system-level integration.
icon url

resx18

04/22/26 9:20 AM

#52942 RE: resx18 #52937

$AMFN is actively preparing to file its Form 10-Q for Q1 2026 with the SEC, which should reflect the value of the intellectual property contributed through the merger into AMFN completed on February 27, 2026. Management believes this filing will provide a more accurate representation of the Company’s intrinsic value than the 2025 annual report, which predated the merger, and, while still conservative relative to projected discounted cash flow estimates, will more closely align with valuation under ASC 805 purchase price accounting.
Bullish
Bullish